Amended Annual Report (10-k/a)
15 October 2014 - 9:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-K/A
Amendment
No. 1
[X] |
ANNUAL
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For
the fiscal year ended June 30, 2014 |
|
|
[
] |
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
|
|
For
the transition period from _________ to ________ |
|
Commission
file number: 000-55155 |
Vantage
Health |
(Exact
name of registrant as specified in its charter) |
Nevada |
93-0659770 |
(State
or other jurisdiction of incorporation or organization) |
(I.R.S.
Employer Identification No.) |
401
Warren Street, Suite 200
Redwood
City, CA |
94063 |
(Address
of principal executive offices) |
(Zip
Code) |
Registrant’s
telephone number: (917) 745-7202
|
|
Securities
registered under Section 12(b) of the Exchange Act:
|
Title
of each class |
Name
of each exchange on which registered |
None |
Not
applicable |
Securities
registered under Section 12(g) of the Exchange Act: |
Title
of each class
Common
stock, par value of $0.001 |
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes
[ ] No [X]
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes
[ ] No [X]
Indicate
by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceeding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No
[ ]
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes [ ] No [X]
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller reporting company [X]
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]
State the
aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at
which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of
the registrant’s most recently completed second fiscal quarter. $4,408,546
Indicate
the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
192,009,927 as of October 14, 2014.
Explanatory
Note
The
purpose of this Amendment No. 1 to the registrant’s Annual Report on Form 10-K for the period ended June 30, 2014, filed
with the Securities and Exchange Commission on October 14, 2014 (the “Form 10-K”), is solely to furnish Exhibit 101
to the Form 10-K. Exhibit 101 provides the financial statements and related notes from the Form 10-K formatted in XBRL (Extensible
Business Reporting Language).
No
other changes have been made to the Form 10-K. This Amendment No. 1 to the Form 10-K speaks as of the original filing date of
the Form 10-K, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update
in any way disclosures made in the original Form 10-K.
SIGNATURES
In accordance
with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Vantage
Health
By:
|
/s/
Joseph C. Peters |
|
Joseph
C. Peters
President,
Chief Executive Officer, Principal Executive Officer,
Chief
Financial Officer, Principal Financial Officer, Principal Accounting Officer and Director |
|
October
14, 2014 |
In accordance
with Section 13 or 15(d) of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated:
By:
|
/s/
Joseph C. Peters |
|
Joseph
C. Peters
President,
Chief Executive Officer, Principal Executive Officer,
Chief
Financial Officer, Principal Financial Officer, Principal Accounting Officer and Director |
|
October 14, 2014 |
By:
|
/s/
Tony van Bijleveld |
|
Tony
van Bijleveld
Director |
|
October 14, 2014 |
By:
|
/s/
Dr. Steven R. Steinhubl |
|
Dr.
Steven R. Steinhubl
Director |
|
October
14, 2014 |
By:
|
/s/
Edward Rollins |
|
Edward
Rollins
Director |
|
October
14, 2014 |
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jul 2023 to Jul 2024